NGM BIOPHARMACEUTICALS INC's ticker is NGM and the CUSIP is 62921N105. A total of 123 filers reported holding NGM BIOPHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 1.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,954,378 | -59.2% | 2,761,102 | -1.2% | 0.00% | – |
Q2 2023 | $7,234,544 | -51.8% | 2,793,260 | -24.1% | 0.00% | – |
Q1 2023 | $15,008,374 | -33.4% | 3,678,523 | -18.1% | 0.00% | -100.0% |
Q4 2022 | $22,535,528 | -55.8% | 4,489,149 | +15.1% | 0.00% | -50.0% |
Q3 2022 | $51,003,000 | +16.9% | 3,899,297 | +14.6% | 0.00% | +100.0% |
Q2 2022 | $43,629,000 | -5.1% | 3,403,208 | +12.9% | 0.00% | 0.0% |
Q1 2022 | $45,971,000 | -12.5% | 3,014,475 | +1.6% | 0.00% | 0.0% |
Q4 2021 | $52,550,000 | +60.2% | 2,967,237 | +90.2% | 0.00% | 0.0% |
Q3 2021 | $32,794,000 | +19.7% | 1,560,125 | +12.3% | 0.00% | 0.0% |
Q2 2021 | $27,392,000 | -58.0% | 1,389,074 | -38.0% | 0.00% | -50.0% |
Q1 2021 | $65,160,000 | +22.5% | 2,241,448 | +27.6% | 0.00% | 0.0% |
Q4 2020 | $53,206,000 | +131.2% | 1,756,261 | +21.4% | 0.00% | +100.0% |
Q3 2020 | $23,014,000 | -17.3% | 1,446,537 | +2.7% | 0.00% | 0.0% |
Q2 2020 | $27,812,000 | +375.8% | 1,408,979 | +197.2% | 0.00% | – |
Q1 2020 | $5,845,000 | -31.2% | 474,007 | +3.1% | 0.00% | – |
Q4 2019 | $8,500,000 | +257.7% | 459,709 | +168.0% | 0.00% | – |
Q3 2019 | $2,376,000 | -3.3% | 171,544 | +2.2% | 0.00% | – |
Q2 2019 | $2,457,000 | – | 167,849 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RHO CAPITAL PARTNERS INC | 3,766,666 | $79,175,000 | 44.14% |
Ponoi II Management, LLC | 1,298,908 | $27,303,000 | 40.46% |
Column Group LLC | 15,396,116 | $323,626,000 | 36.81% |
Ponoi Management, LLC | 1,298,908 | $27,303,000 | 24.24% |
Euclidean Capital LLC | 832,274 | $17,494,000 | 8.50% |
StepStone Group LP | 1,573,357 | $33,072,000 | 2.14% |
Octagon Capital Advisors LP | 200,000 | $4,204,000 | 1.04% |
Redmile Group, LLC | 2,505,118 | $52,658,000 | 0.92% |
BVF INC/IL | 955,000 | $20,074,000 | 0.78% |
Boxer Capital, LLC | 500,000 | $10,510,000 | 0.37% |